Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2012 | 01-2012 | 10-2011 | 07-2011 | 04-2011 | |
| Sales | 1,381 | 2,396 | 1,741 | 1,634 | 1,544 |
| Cost of Goods | 1,532 | 1,329 | 1,081 | 902 | 993 |
| Gross Profit | -151 | 1,067 | 660 | 732 | 551 |
| Operating Expenses | 2,983 | 3,169 | 3,210 | 3,848 | 4,375 |
| Operating Income | -2,602 | -1,773 | -2,469 | -2,214 | -2,831 |
| Other Income | 38 | 54 | 120 | 177 | 100 |
| Pre-tax Income | -2,564 | -1,719 | -2,349 | -2,037 | -2,731 |
| Net Income Continuous | -2,564 | -1,719 | -2,349 | -2,037 | -2,742 |
| Net Income | $-2,564 | $-1,719 | $-2,349 | $-2,037 | $-2,742 |
| EPS Basic Total Ops | N/A | -0.48 | -0.60 | -0.48 | -0.96 |
| EPS Basic Continuous Ops | N/A | -0.44 | -0.60 | -0.53 | -0.98 |
| EPS Diluted Total Ops | N/A | -0.48 | -0.60 | -0.48 | -0.96 |
| EPS Diluted Continuous Ops | N/A | -0.44 | -0.60 | -0.53 | -0.98 |
| EBITDA(a) | $-2,562 | $-1,757 | $-2,449 | $-2,185 | $-2,819 |